Lisa E. Danzig, MD
Dr. Lisa E. Danzig is an infectious disease specialist in San Francisco, California. She has spent more than 20 years within the pharmaceutical industry (Chiron, Novartis, Grifols, PaxVax) developing vaccines, diagnostics, and drugs, and is currently advising companies and investors.
Dr. Danzig studied biology at Reed College and medicine at OHSU. In San Francisco, she completed internal medicine residency training at CPMC, in Atlanta, served as an Epidemic Intelligence Service Officer with the US CDC, with a special focus on hospital acquired infections. Following CDC, she completed an Infectious Diseases fellowship in San Francisco, at the UCSF-Mt. Zion campus. She joined Chiron in 1997 and spent the following decade leading meningococcal vaccine development teams (Menjugate, Menveo, Bexsero). After Novartis acquired Chiron in 2006, she moved to Siena, Italy to lead early clinical development. With the Business Development group, she was responsible for clinical licensing evaluation, and led the R&D integration team for an acquisition in China (Tianyuan Biopharm, Hangzhou, CN). She returned to the US to lead the Medical and Scientific Affairs group for Novartis Diagnostics, a global market leader that provided blood screening solutions for nucleic acid detection of HIV, HBV, HCV, WNV and emerging threats (Dengue, Chikungunya, Zika, Babesia). After the acquisition of Novartis Diagnostics by Grifols, she joined PaxVax (first as a special advisor, and subsequently as EVP and Chief Medical Officer). PaxVax had a social mission to provide vaccines for diseases that were overlooked by the industry and yet of importance to travelers (e.g., Cholera, Typhoid). Emergent Biosolutions acquired PaxVax in October 2018. Dr. Danzig currently provides advisory services to investor groups (VC, PE, Philanthropists) and biotechnology companies. Serves as an independent director at OrSense (non-invasive hemoglobin monitoring system). In the non-profit world, serves on the advisory board of the Lemelson Foundation (improving lives through invention), as a director of the Karuna Foundation (adaptation/climate change) and Sustainable Sciences Institute (building global public health research capacity), and as VP on the board of the International Society of Travel Medicine Foundation (ISTMF).
Specialty: Infectious disease specialist dealing with a broad array of emerging infectious diseases, including respiratory and blood-borne pathogens. Infectious Diseases and specialty training: Epidemic Intelligence Service Officer (EIS Officer) at the CDC and Infectious Diseases Fellowship at UCSF-Mount Zion.
Medical School & Residency: Oregon Health & Science University School of Medicine, Portland, Oregon and California Pacific Medical Center, San Francisco, CA.